Estadístiques de Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma
Visites totals
| views | |
|---|---|
| Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma | 244 |
Visites totals per mes
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 7 |
| September 2024 | 6 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| bellmunt-bjc-ever.pdf(legacy) | 214 |
| bellmunt-bjc-ever.pdf | 4 |
Vistes principals per país
| views | |
|---|---|
| United States | 175 |
| Spain | 26 |
| Sweden | 8 |
| Ireland | 6 |
| Germany | 5 |
| India | 4 |
| United Kingdom | 3 |
| Turkey | 3 |
| France | 2 |
| China | 1 |
| Egypt | 1 |
| Japan | 1 |
| South Korea | 1 |
| Mexico | 1 |
| Malaysia | 1 |
| Netherlands | 1 |
| Portugal | 1 |
| Russia | 1 |
| Singapore | 1 |
| Taiwan | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Ashburn | 33 |
| Fairfield | 33 |
| Cambridge | 18 |
| San Ramon | 17 |
| Barcelona | 12 |
| Redwood City | 9 |
| Dublin | 6 |
| Mountain View | 6 |
| Menlo Park | 4 |
| Istanbul | 3 |
| San Diego | 3 |
| Tustin | 3 |
| Ann Arbor | 2 |
| Boardman | 2 |
| Katy | 2 |
| Nottingham | 2 |
| Seattle | 2 |
| Andover | 1 |
| Augusta | 1 |
| Bangalore | 1 |
| Belmont | 1 |
| Buffalo | 1 |
| Clover | 1 |
| Dallas | 1 |
| Delhi | 1 |
| Durham | 1 |
| Ernakulam | 1 |
| Gütersloh | 1 |
| Madrid | 1 |
| Mexico | 1 |
| Montpellier | 1 |
| Mumbai | 1 |
| New York | 1 |
| Port Said | 1 |
| Premiá De Mar | 1 |
| San Francisco | 1 |
| Seoul | 1 |
| Shah Alam | 1 |
| Shenzhen | 1 |
| Singapore | 1 |
| Taipei | 1 |
| Tampa | 1 |
| Utrecht | 1 |
| Valencia | 1 |
| Washington | 1 |